Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Rezzayo
Rezzayo
departments:
感染科
drug:
注射剂
Active:
rezafungin
indication:
REZZAYO是一种棘白菌素抗真菌药,适用于18岁以上成年人患者对念珠菌血症和侵袭性念珠菌感染。 使用限制 REZZAYO尚未在患有心内膜炎、骨髓炎和慢性疲劳的患者中进行研究,和念珠菌引起的脑膜炎。
Licensor:
Cidara Therapeutics, Inc.
Approved Country/Region:
FDA
Approval time:
2023-03-22